Form 4: IDEXX Laboratories Director Asha Collins Reports Stock Transactions
SEC Form 4 Filing
Director Asha Collins reports the acquisition and disposal of IDEXX Laboratories Inc. stock and derivative securities.
Summary
- On May 6, 2024, Asha Collins, a director of IDEXX Laboratories Inc., reported transactions involving the company's stock.
- Collins acquired 257 shares of common stock through the exercise of restricted stock units.
- Collins also acquired 609 non-qualified stock options with an exercise price of $476.87, exercisable on May 6, 2024, and expiring on May 5, 2034.
- Additionally, Collins acquired 262 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in company stock.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding the director's holdings and trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/06/2024 | Date of earliest transaction: Acquisition and disposal of securities. |
| 05/06/2024 | Grant date of non-qualified stock options. |
| 05/05/2034 | Expiration date of non-qualified stock options. |
| 05/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.